Survival of renal allografted dogs after limited therapy with cyclosporine and the PAF antagonist WEB 2170.
Metcalfe
S M
SM
Department of Surgery, Addenbrooke's Hospital, Cambridge, England.
Watson
C J
CJ
Collier
D G
DG
DaCosta
M
M
Friend
P J
PJ
Pollard
S G
SG
Luddington
R
R
Calne
R Y
RY
D000818:Animals; D001381:Azepines / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006085:Graft Survival; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D014230:Triazoles / Q000627:therapeutic use*
D001381:Azepines; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D010972:Platelet Activating Factor; D014230:Triazoles; C063964:bepafant